Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Parkinson's Foundation Announces State Level Prevalence Medicare Costs of Parkinson's Disease - Diagnosis of Parkinson’s Associated with Greater Spending


NEW YORK & MIAMI, January 24, 2019—A Parkinson’s Foundation study recently published in the scientific journal, npj Parkinson’s Disease, found that a diagnosis of Parkinson’s disease (PD) was associated with greater healthcare use and spending.

“This state-level analysis will help inform policymakers on the societal costs of PD and target areas where PD patients may have more needs,” said James Beck, PhD, Chief Scientific Officer at the Parkinson’s Foundation. “We must realign our national priorities to support increased funding for research and care for people living with PD.”

The study examined state-level variations in PD prevalence, patient characteristics, Medicare spending, out-of-pocket costs, and health service utilization, using data on 27.5 million Medicare beneficiaries in the U.S. in 2014. Nationally, 45.8% of individuals diagnosed with PD in the Medicare dataset were women, and 26.1% were aged 85 and above. The District of Columbia, New York, Illinois, Connecticut, and Florida had the highest prevalence of PD among Medicare beneficiaries in the US.

“Although women diagnosed with PD are a sizable portion of the patient population, they are highly underrepresented in PD research and clinical trials,” said Allison W. Willis, MD, MS, an assistant professor of Neurology and Biostatistics and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania, a Parkinson’s Foundation Center of Excellence, and senior author of the paper. “Improving PD outcomes will require increased attention to women who have less access to specialized care.”

In 2014, Medicare paid approximately $7.9 billion for health care services delivered to people with PD. The costliest services were inpatient care, skilled nursing facility care, hospital outpatient care, and home health. For all health care services, Medicare and out-of-pocket spending was significantly higher for beneficiaries with PD than without PD.  

Added John L. Lehr, CEO of the Parkinson’s Foundation: “Due to the aging of the population, PD is on the rise in the U.S. This study highlights the growing importance of optimizing care and treatment for people with the disease today.”

The regions with the highest prevalence of PD are not consistent with the regions of highest spending; however, state costs will continue to rise as PD prevalence in the U.S. increases. The Parkinson’s Foundation Parkinson’s Prevalence Project estimates that 1.2 million people will be living with PD by 2030. Further research to understand the economic burden of PD is needed to inform future health care policy and the state and federal level.  

To learn more about the Parkinson’s Foundation Prevalence Project, visit Parkinson.org/PrevalenceProject.

###

About the Parkinson’s Foundation 
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson’s Disease 
Affecting nearly one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Thursday, January 24, 2019
Parkinson’s Foundation Announces First Aware in Care Ambassadors
Monday, February 25, 2019

NEW YORK & MIAMI — February 25, 2019 — The Parkinson’s Foundation today announced the first members of its Aware in Care Ambassador Pilot Program, a volunteer group organized to help distribute Aware in Care kits that serve to bolster best practices in treating patients with Parkinson’s disease to both patients and healthcare providers.

Parkinson’s Foundation Hosts Professional Education Training in Iowa City
Wednesday, February 13, 2019

Partnership with the University of Iowa Hospitals & Clinics

Breaking News: Boston Scientific: Boston Scientific Launches Vercise™ Primary Cell And Vercise Gevia™ Deep Brain Stimulation Systems With Directional Leads
Thursday, January 24, 2019

Parkinson's Foundation cited in Boston Scientific Press Release: MARLBOROUGH, Mass., Jan. 24, 2019  -- Boston Scientific Corporation (NYSE: BSX) has launched the Vercise™Primary Cell (PC) and Vercise Gevia™ Deep Brain Stimulation (DBS) Systems featuring the Vercise Cartesia™ Directional Lead. The new systems, which were recently approved by the U.S.

Parkinson's Foundation Announces State Level Prevalence Medicare Costs of Parkinson's Disease - Diagnosis of Parkinson’s Associated with Greater Spending
Thursday, January 24, 2019


NEW YORK & MIAMI, January 24, 2019—A Parkinson’s Foundation study recently published in the scientific journal, npj Parkinson’s Disease, found that a diagnosis of Parkinson’s disease (PD) was associated with greater healthcare use and spending.

Breaking News: FDA Approves Treatment for “Off” Periods in Parkinson’s
Thursday, December 27, 2018

The U.S. Food and Drug Administration (FDA) has approved INBRIJA™, a levodopa inhalation powder developed by Acorda Therapeutics, as a treatment for “off” periods in people with Parkinson’s disease (PD) who are treated with carbidopa/levodopa.

Quick Facts about INBRIJA™:

Parkinson’s Foundation Hosts Its First-Ever Medical Marijuana and Parkinson’s Disease Conference
Tuesday, December 4, 2018

NEW YORK AND MIAMI— December 4, 2018—The Parkinson’s Foundation will host its first-ever conference focused on medical marijuana and Parkinson’s disease (PD) in Denver, CO, March 6-7, 2019.

Parkinson's Foundation Hosts National Forum for Women Living with Parkinson's Disease
Wednesday, November 7, 2018

MIAMI & NEW YORK — NOVEMBER 7, 2018 —The Parkinson’s Foundation hosted the first national forum for women with Parkinson’s disease (PD) on October 19 at Baylor College of Medicine, a Parkinson’s Foundation Center of Excellence, in Houston, TX.

Parkinson’s Foundation Announces Expansion of Community Grants Program to Address Unmet Community Needs
Thursday, November 1, 2018

NEW YORK & MIAMI — November 1, 2018 — The Parkinson’s Foundation is proud to announce that it is requesting applications for community grants to be awarded nationwide for health, wellness and education programs that address unmet needs in the Parkinson’s disease (PD) community. In 2019, the Parkinson’s Foundation will award $1.2 million in community grants.

Parkinson’s Foundation Hosts Free Bilingual Caregiver Summit
Tuesday, October 30, 2018

MIAMI AND NEW YORK—October 30, 2018—The Parkinson’s Foundation will host a Caregiver Summit – “Cumbre Para Cuidadores” – geared specifically toward caregivers of people living with Parkinson’s disease (PD).

Parkinson’s Foundation Adds James Monhart to its Board of Directors
Monday, October 29, 2018

NEW YORK & MIAMI, October 29, 2018—The Parkinson’s Foundation today announced the election of James F.T. Monhart to its board of directors.

Pages

mail icon

Subscribe here to get the latest news on treatments, research and other updates.